Page last updated: 2024-08-24

imiquimod and isomethyleugenol

imiquimod has been researched along with isomethyleugenol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, M; Si, X	1

Other Studies

1 other study(ies) available for imiquimod and isomethyleugenol

Article	Year
Rapamycin ameliorates psoriasis by regulating the expression and methylation levels of tropomyosin via ERK1/2 and mTOR pathways in vitro and in vivo. Experimental dermatology, 2018, Volume: 27, Issue:10 Topics: Animals; Cell Proliferation; Cytoskeleton; Down-Regulation; Female; Gene Expression; HEK293 Cells; Humans; Imiquimod; Immunosuppressive Agents; Keratinocytes; Male; MAP Kinase Signaling System; Methylation; Mice; Psoriasis; S Phase Cell Cycle Checkpoints; Sirolimus; TOR Serine-Threonine Kinases; Tropomyosin	2018

Article

Year

Rapamycin ameliorates psoriasis by regulating the expression and methylation levels of tropomyosin via ERK1/2 and mTOR pathways in vitro and in vivo.

Experimental dermatology, 2018, Volume: 27, Issue:10

Topics: Animals; Cell Proliferation; Cytoskeleton; Down-Regulation; Female; Gene Expression; HEK293 Cells; Humans; Imiquimod; Immunosuppressive Agents; Keratinocytes; Male; MAP Kinase Signaling System; Methylation; Mice; Psoriasis; S Phase Cell Cycle Checkpoints; Sirolimus; TOR Serine-Threonine Kinases; Tropomyosin

2018